Kristin King

Kristin King-Jankiewicz, MBA, serves as the Chief Business Officer at FiteBac Technologies since June 2024, following a distinguished career in various leadership roles. With extensive experience in corporate development and mergers and acquisitions, Kristin held the position of Vice President at Defibtech, LLC from 2019 to 2024 and has been Head of Group Management at Boston Harbor Angels Inc. since 2017. Kristin also contributed as an Executive in Residence at Yale Ventures from 2018 to 2024 and led significant business development initiatives at Ansell from 2011 to 2017. Prior roles include Interim Director at BD Medical and Brand Manager at Pfizer, showcasing a strong track record in marketing and sales across healthcare sectors. Kristin's educational background includes an MBA in Finance and Marketing from NYU Stern School of Business and a B.S. in Bio-engineering and Mathematics from Syracuse University.